secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2024-01-25T23:59:59+00:00
Accession:  0001493152-24-003756
Event type: regulatory
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera gets Nasdaq extension until May 20, 2024 to regain compliance
-------------------------------------------------------------------------

- Nasdaq granted a 180-day extension from Nov 22, 2023 (new deadline May 20, 2024) to regain compliance.
- Company had submitted a compliance plan on January 8, 2024, after initial delisting notice.
- Must demonstrate compliance with Nasdaq continued listing requirements by the extended deadline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315224003756/0001493152-24-003756-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315224003756/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-003756

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer